World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Chemistry 45 16453 14849 41 36 136 7332

Brian D. Palmer publications per year

The chart shows the history of publications by Brian D. Palmer between 1980 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Brian D. Palmer published across 46 years, from 1980 to 2025, averaging 3.5 papers a year. Output peaked at 11 publications in 2010. 2 of the 159 publications appeared in the last two years.

No. of publications
2 4 6 8 10
Bar chart. Horizontal axis: year, 1980 to 2025. Vertical axis: number of publications, 0 to 11. Peak 11 publications in 2010. 1980: 1 publication 1981: 1 publication 1982: 6 publications 1983: 1 publication 1984: 1 publication 1985: 1 publication 1986: 1 publication 1987: 1 publication 1988: 3 publications 1989: 3 publications 1990: 6 publications 1991: 4 publications 1992: 7 publications 1993: 5 publications 1994: 6 publications 1995: 5 publications 1996: 10 publications 1997: 3 publications 1998: 3 publications 1999: 3 publications 2000: 4 publications 2001: 0 publications 2002: 2 publications 2003: 4 publications 2004: 4 publications 2005: 1 publication 2006: 1 publication 2007: 1 publication 2008: 3 publications 2009: 3 publications 2010: 11 publications 2011: 2 publications 2012: 2 publications 2013: 3 publications 2014: 4 publications 2015: 4 publications 2016: 2 publications 2017: 6 publications 2018: 4 publications 2019: 5 publications 2020: 4 publications 2021: 3 publications 2022: 3 publications 2023: 10 publications 2024: 0 publications 2025: 2 publications
1980 2025

159 publications in total across all disciplines

View publications per year as a table
Brian D. Palmer: publications per year, 1980 to 2025
Year Publications
1980 1
1981 1
1982 6
1983 1
1984 1
1985 1
1986 1
1987 1
1988 3
1989 3
1990 6
1991 4
1992 7
1993 5
1994 6
1995 5
1996 10
1997 3
1998 3
1999 3
2000 4
2001 0
2002 2
2003 4
2004 4
2005 1
2006 1
2007 1
2008 3
2009 3
2010 11
2011 2
2012 2
2013 3
2014 4
2015 4
2016 2
2017 6
2018 4
2019 5
2020 4
2021 3
2022 3
2023 10
2024 0
2025 2
Total 159
Download as CSV

Brian D. Palmer publications per year - data summary

  • Brian D. Palmer, a Chemistry scholar from University of Auckland, has 159 publications recorded across 46 years, from 1980 to 2025.
  • The oldest publication on record dates to 1980 and the most recent to 2025.
  • The most productive year is 2010, with 11 publications.
  • The least productive years with any output are 1980, 1981, 1983, 1984 and others, with 1 publication each.
  • 2 of the 46 years in the span carry no publications at all (2001 and 2024).
  • The rate of publication averages 3.5 papers per year over the whole span, or 3.6 per year counting only the 44 years with at least one publication.
  • The last 5 years on the chart (2021-2025) hold 18 publications, 11% of the career total.
  • Split into equal eras - 1980-1995: 52 publications (3.3 per year); 1996-2011: 55 publications (3.4 per year); 2012-2025: 52 publications (3.7 per year).
  • Comparing the opening and closing eras, the overall trend of publication is broadly steady.

Brian D. Palmer publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Brian D. Palmer sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 63 bars. Horizontal axis: publications, 61–80 to 1,295+. Vertical axis: number of scientists, 0 to 1,350. Most scientists, 1,350, have 161–180 publications. The last bar groups every scientist with 1,295 publications or more. The highlighted bar, 121–140 publications, is where this scientist sits. 61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61–80 publications 1,295+

This scientist: 136 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

View publications distribution as a table
Number of Chemistry scientists by publication count, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
Publications Scientists This scientist
61–80 66
81–100 302
101–120 623
121–140 918 136
141–160 1,218
161–180 1,350
181–200 1,344
201–220 1,281
221–240 1,216
241–260 1,100
261–280 979
281–300 939
301–320 764
321–340 643
341–360 628
361–380 522
381–400 459
401–420 397
421–440 327
441–460 270
461–480 265
481–500 252
501–520 201
521–540 185
541–560 148
561–580 148
581–600 132
601–620 114
621–640 104
641–660 91
661–680 92
681–700 73
701–720 57
721–740 54
741–760 67
761–780 45
781–800 46
801–820 39
821–840 32
841–860 36
861–880 29
881–900 26
901–920 24
921–940 14
941–960 23
961–980 28
981–1,000 15
1,001–1,020 29
1,021–1,040 12
1,041–1,060 19
1,061–1,080 12
1,081–1,100 6
1,101–1,120 8
1,121–1,140 12
1,141–1,160 5
1,161–1,180 6
1,181–1,200 14
1,201–1,220 7
1,221–1,240 2
1,241–1,260 6
1,261–1,280 4
1,281–1,294 6
1,295+ 100
Download as CSV

Brian D. Palmer publication distribution in Chemistry in 2026 - data summary

  • The chart plots the publication count of all 17,934 Chemistry scientists ranked by Research.com in 2026, grouped into 63 ranges running from 61–80 to 1,295+ publications.
  • Brian D. Palmer, a Chemistry scholar from University of Auckland, records 136 publications - the 9th percentile of the discipline.
  • 9% of ranked Chemistry scientists score the same or lower than Brian D. Palmer, and about 91% score higher.
  • The median of the discipline falls in the 241–260 publications range, and Brian D. Palmer ranks below the median.
  • The most crowded range is 161–180 publications, holding 1,350 scientists (8% of the field).
  • 77% of the field sits in the lowest quarter of the value range (up to 361–380 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 1,295 publications or more, 100 scientists in all (<1% of the field).

Brian D. Palmer D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Brian D. Palmer sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 61 bars. Horizontal axis: D-Index, 40–41 to 159+. Vertical axis: number of scientists, 0 to 1,051. Most scientists, 1,051, have 56–57 D-Index. The last bar groups every scientist with 159 D-Index or more. The highlighted bar, 44–45 D-Index, is where this scientist sits. 40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40–41 D-Index 159+

This scientist: 45 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

View D-Index distribution as a table
Number of Chemistry scientists by D-index, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
D-Index Scientists This scientist
40–41 289
42–43 612
44–45 808 45
46–47 776
48–49 835
50–51 861
52–53 872
54–55 933
56–57 1,051
58–59 930
60–61 882
62–63 834
64–65 731
66–67 775
68–69 683
70–71 646
72–73 561
74–75 501
76–77 437
78–79 388
80–81 354
82–83 292
84–85 275
86–87 254
88–89 235
90–91 185
92–93 192
94–95 155
96–97 163
98–99 125
100–101 105
102–103 105
104–105 112
106–107 88
108–109 68
110–111 69
112–113 65
114–115 79
116–117 61
118–119 44
120–121 37
122–123 40
124–125 33
126–127 26
128–129 34
130–131 35
132–133 25
134–135 27
136–137 17
138–139 16
140–141 20
142–143 20
144–145 15
146–147 9
148–149 9
150–151 16
152–153 11
154–155 9
156–157 3
158 3
159+ 98
Download as CSV

Brian D. Palmer D-index placement in Chemistry in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 17,934 Chemistry scientists ranked by Research.com in 2026, grouped into 61 ranges running from 40–41 to 159+ D-Index.
  • Brian D. Palmer, a Chemistry scholar from University of Auckland, records 45 D-Index - the 10th percentile of the discipline.
  • 10% of ranked Chemistry scientists score the same or lower than Brian D. Palmer, and about 90% score higher.
  • The median of the discipline falls in the 62–63 D-Index range, and Brian D. Palmer ranks below the median.
  • The most crowded range is 56–57 D-Index, holding 1,051 scientists (6% of the field).
  • 70% of the field sits in the lowest quarter of the value range (up to 70–71 D-Index), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 159 D-Index or more, 98 scientists in all (<1% of the field).

Overview

Brian D. Palmer is affiliated with the University of Auckland in New Zealand. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with specific focus areas in Molecular Biology, Infectious Diseases, Physiology, Pharmacology, and Biological Psychiatry.

The scientist's work addresses major topics including Tuberculosis Research and Epidemiology, Cancer therapeutics and mechanisms, Biochemical and Molecular Research, Tryptophan and brain disorders, ATP Synthase and ATPases Research, Synthesis and biological activity, and Circadian rhythm and melatonin.

Frequent publication venues where Brian D. Palmer's research appears include Bioorganic & Medicinal Chemistry, Pharmaceuticals, Tetrahedron Letters, Frontiers in Neuroscience, and Molecules.

Key recent papers authored or co-authored by Brian D. Palmer are:

  • Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis (2020, Bioorganic & Medicinal Chemistry)
  • Synthetic Studies to Help Elucidate the Metabolism of the Preclinical Candidate TBAJ-876-A Less Toxic and More Potent Analogue of Bedaquiline (2020, Molecules)
  • Synthetic studies towards isomeric pyrazolopyrimidines as potential ATP synthesis inhibitors of Mycobacterium tuberculosis. Structural correction of reported N-(6-(2-(dimethylamino)ethoxy)-5-fluoropyridin-3-yl)-2-(4-fluorophenyl)-5-(trifluoromethyl)pyrazolo[1,5-α]pyrimidin-7-amine (2021, Tetrahedron Letters)
  • Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis (2021, European Journal of Medicinal Chemistry)
  • Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay (2021, Bioorganic & Medicinal Chemistry)

Their frequent co-authors include Hamish S. Sutherland, Peter J. Choi, Christopher B. Cooper, William A. Denny, and Scott G. Franzblau.

Best Publications

  • Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.

    Manju Kanamala;William R. Wilson;Mimi Yang;Brian D. Palmer

  • Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.

    J. B. Smaill;B. D. Palmer;G. W. Rewcastle;W. A. Denny

  • Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.

    David C. Ware;Brian D. Palmer;William R. Wilson;William A. Denny

  • Relationships Between Hydrophobicity, Reactivity, Accumulation And Peripheral Nerve Toxicity Of A Series Of Platinum Drugs

    D. Screnci;M.J. McKeage;P. Galettis;T.W. Hambley

  • Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor

    Gordon W. Rewcastle;Brian D. Palmer;Alexander J. Bridges;H. D. Hollis Showalter

  • Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor.

    Gordon W. Rewcastle;Brian D. Palmer;Andrew M. Thompson;Alexander J. Bridges

  • Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells

    Leslie A. Parsels;Meredith A. Morgan;Daria M. Tanska;Joshua D. Parsels

  • Tyrosine Kinase Inhibitors. 11. Soluble Analogues of Pyrrolo- and Pyrazoloquinazolines as Epidermal Growth Factor Receptor Inhibitors: Synthesis, Biological Evaluation, and Modeling of the Mode of Binding

    Brian D. Palmer;Susanne Trumpp-Kallmeyer;David W. Fry;James M. Nelson

  • Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.

    Brian D. Palmer;William R. Wilson;Susan M. Pullen;William A. Denny

  • Synthesis and Structure−Activity Relationships of Aza- and Diazabiphenyl Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)

    Iveta Kmentova;Hamish S. Sutherland;Brian D. Palmer;Adrian Blaser

  • Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).

    Brian D. Palmer;Andrew M. Thompson;Hamish S. Sutherland;Adrian Blaser

  • 4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution.

    Brian D Palmer;Andrew M Thompson;R John Booth;Ellen M Dobrusin

  • Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase.

    G.M. Anlezark;R.G. Melton;R.F. Sherwood;W.R. Wilson

  • Synthesis, reduction potentials, and antitubercular activity of ring A/B analogues of the bioreductive drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).

    Andrew M. Thompson;Adrian Blaser;Robert F. Anderson;Sujata S. Shinde

  • Potential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides

    Brian D. Palmer;Gordon W. Rewcastle;Graham J. Atwell;Bruce C. Baguley

  • Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells.

    Brian D. Palmer;William R. Wilson;Stephen Cliffe;William A. Denny

  • Mustard prodrugs for activation by Escherichia coli nitroreductase in gene-directed enzyme prodrug therapy

    Frank Friedlos;William A. Denny;Brian D. Palmer;Caroline J. Springer

  • DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II).

    Ho H. Lee;Brian D. Palmer;Bruce C. Baguley;Michael Chin

  • Structure-activity relationships for 2-anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as inhibitors of the cellular checkpoint kinase Wee1.

    Brian D. Palmer;Jeff B. Smaill;Gordon W. Rewcastle;Ellen M. Dobrusin

  • Total synthesis of the ionophore antibiotic X-14547A (Indanomycin)

    Martin P. Edwards;Steven V. Ley;Simon G. Lister;Brian D. Palmer

  • 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel.

    Hamish S. Sutherland;Amy S.T. Tong;Peter J. Choi;Adrian Blaser

Frequent Co-Authors

William A. Denny
William A. Denny University of Auckland
William R. Wilson
William R. Wilson University of Auckland
Bruce C. Baguley
Bruce C. Baguley University of Auckland
Scott G. Franzblau
Scott G. Franzblau University of Illinois at Chicago
David W. Fry
David W. Fry Pfizer (United States)
Edward N. Baker
Edward N. Baker University of Auckland
Colin J. Jackson
Colin J. Jackson Australian National University
Steven V. Ley
Steven V. Ley University of Cambridge
Jun Lu
Jun Lu Zhejiang University
Lynnette R. Ferguson
Lynnette R. Ferguson University of Auckland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Chemistry in the USA opens doors to various interdisciplinary careers. Students interested in expanding their expertise often consider related fields like criminal justice, paralegal studies, and pharmaceutical sales. Understanding the associated costs and educational pathways can help make informed decisions.

For those curious about the financial commitment, learning how much is criminal justice school is a good starting point. This insight is particularly useful for individuals considering dual interests in science and law enforcement or regulatory affairs.

An alternative route is pursuing a criminal justice associate degree online, which offers flexibility and foundational knowledge, potentially complementing a chemistry background for careers in forensic science or legal compliance.

Additionally, paralegal roles related to chemical patents or environmental law can be lucrative. Understanding paralegal salary trends helps gauge the financial benefits of entering this field alongside chemistry expertise.

Lastly, a career as a pharmaceutical sales representative merges science and business skills. Prospective candidates should review pharma sales rep salary and career pathways to understand growth potential within the chemistry-related industry.

Best Scientists Citing Brian D. Palmer

Trending Scientists

Recently Published Articles